Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today that two oral and four poster presentations related to its Ac-225 or Actinium-225 based ARC's or Antibody Radiation-Conjugates...

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will...

ORACLE HOSPITALITY CONNECT -- Updates to Oracle Hospitality OPERA Cloud Service continue to redefine how hoteliers engage and serve guests, from the time they make their reservations through to...

AllianceRx Walgreens Prime announced results from a new study demonstrating the company's oral oncology split-fill program resulted in a high rate of patient adherence, significantly reduced...

A recent study found patients with hemophilia A experienced fewer bleeds while undergoing newer extended half-life (EHL) therapy on a prophylactic (preventive) basis. The retrospective study was...

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company, announced today acceptance of their abstract for late-breaker presentation on LPCN 1144 clinical results as part of The...

Sony Corporation ("Sony") wrapped its third year at SXSW (South by Southwest), the world's largest creative business festival in Austin, Texas. Sony hosted a variety of discussion sessions led by...

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will be showcasing the industry's most comprehensive...

Genesys® (www.genesys.com), the global leader in omnichannel customer experience and contact center solutions, invites Greater Toronto Area tech enthusiasts, students, developers, product...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of eight studies at the 2019 American College of...